We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies. More information Accept
Expertise / CNS FOCUS

CNS STRATEGIC VISION

The NuPharm Group is focused on

the development, manufacturing and marketing of medicinal products for Central Nervous System PATHOLOGIES

Our goal is to become the
European leader
in pharmaceutical products for this therapeutic area comprising complex disease states which can affect any member of any society at any point in life and representing a major challenge for medicine

CNS
Focus

The Group's outstanding development capability allows us to offer our clients a wide range of products in CNS through subsidiaries located in several major European countries
GROUP SUBSIDIARIES

OUR COMMERCIAL NETWORK LEVERAGE

Allows us to reach
  • Pharmacists
  • Psychiatrists
  • Neurologists
  • Geriatricians
  • Pain specialists
  • HOSPITAL CNS SPECIALISTS
> 100
MOLECULES IN CNS
550
PHARMACEUTICAL FORMS
25%
SALES & MARKETING EMPLOYEES
250,000
CALLS TO CNS SPECIALISTS / YEAR

NUPHARM GROUP BRANDS

NuPharm Group owns and operates three European distribution and marketing companies with a special focus on CNS pathologies
  • FOCUS_CNS__METAS_BRAND01_ALT
    neuraxpharm is the largest player in the German CNS market with a 17% share in developing, sourcing and distributing finished dosage forms
    More
  • FOCUS_CNS__METAS_BRAND02_ALT
    Qualigen is focused on the commercialisation of branded CNS products and EFG generics in Spain, selling directly to pharmacies, hospitals, wholesalers, psychiatrists, neurologists and pain specialists
    More
  • FOCUS_CNS__METAS_BRAND03_ALT
    FB Health is a company specialised in researching, developing and commercialising innovative CNS drugs and nutraceuticals in Italy
    More

NUPHARM GROUP, 
The leading European
experts in CNS